首页> 外国专利> HER2-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS

HER2-TARGETING MOLECULES COMPRISING DE-IMMUNIZED, SHIGA TOXIN A SUBUNIT SCAFFOLDS

机译:HER2靶向分子,包含去免疫的滋贺毒素亚基脚手架

摘要

Provided herein are HER2-targeting molecules comprising Shiga toxin A Subunit derived polypeptides having 1) de-immunization and 2) reduced, protease-cleavage sensitivity while retaining Shiga toxin function(s), such as, e.g., potent cytotoxicity via ribosome inhibition. Certain HER2-targeting molecules of the present invention exhibit reduced immunogenic potential in mammals and are well-tolerated by mammals while retaining aforementioned features. The HER2-targeting molecules of the present invention have uses for selectively killing specific cells (e.g., HER positive tumor cells); for selectively delivering cargos to specific cells (e.g., HER positive tumor cells), and as therapeutic and/or diagnostic molecules for treating and diagnosing a variety of conditions, including cancers and tumors involving the expression or over-expression of cell-surface HER2.
机译:本文提供了靶向HER2的分子,其包含志贺毒素A亚基衍生的多肽,其具有1)去免疫和2)降低的蛋白酶切割敏感性,同时保留志贺毒素功能,例如,通过核糖体抑制的有效细胞毒性。本发明的某些靶向HER2的分子在哺乳动物中表现出降低的免疫原性并且在保留上述特征的同时被哺乳动物很好地耐受。本发明的靶向HER2的分子具有用于选择性杀死特定细胞(例如,HER阳性肿瘤细胞)的用途。用于选择性地将货物递送至特定细胞(例如HER阳性肿瘤细胞),以及作为治疗和/或诊断分子用于治疗和诊断多种疾病,包括涉及表达或过度表达细胞表面HER2的癌症和肿瘤。

著录项

  • 公开/公告号CA3097178A1

    专利类型

  • 公开/公告日2019-10-24

    原文格式PDF

  • 申请/专利权人 MOLECULAR TEMPLATES INC.;

    申请/专利号CA20193097178

  • 发明设计人 POMA ERIC;WILLERT ERIN;

    申请日2019-04-16

  • 分类号A61K39;A61K47/68;A61P35;C07K14/245;C07K14/25;C07K16/32;C12N9/10;C12N9/24;C12N15/62;

  • 国家 CA

  • 入库时间 2022-08-21 11:58:19

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号